NEW YORK (GenomeWeb News) – Genetic mutations in prostate cancer appear to arise all of a sudden, a team of investigators led by Weill Cornell Medical College's Mark Rubin; Levi Garraway of Harvard Medical School, the Broad Institute, and Dana-Farber Cancer Institute; and Francesca Demichelis from the University of Trento in Italy, reported in Cell yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.